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Background: Despite the huge numbers of the internationally produced and imple-
mented Clinical Practice Guidelines (CPGs), the compliance with them is still low in health 
care. This study aimed at assessing the attitudes of Palestinian health-care professionals 
toward the most perceived factors influencing the adherence to the CPG for Diabetes 
Mellitus in the Primary Health-care centers of the Ministry of Health (PHC-MoH) and the 
Primary Health-care centers of the United Nations Relief and Works Agency for Palestine 
Refugees (PHC-UNRWA) using a validated questionnaire.
Methods: A cross-sectional design was employed with a census sample of all Palestinian 
family doctors and nurses (n = 323). The Cabana theoretical framework was used to 
develop a study questionnaire. A cross cultural adaptation framework was followed to 
develop the Arabic version questionnaire. The psychometric properties of Arabic version 
were finally assessed.
results: The Arabic version questionnaire showed a good construct validity and 
internal consistency reliability. The overall adherence level to the diabetic guideline was 
disappointingly suboptimal 51.5% (47.3% in the PHC-MoH and 55.5% in the PHC-
UNRWA) P = 0.000. The most frequently perceived barriers in the PHC-MoH were lack 
of incentives, lack of resources, and lack of guideline trustworthiness, whereas the lack 
of time and the lack of guideline trustworthiness were the most prominent barriers in 
the PHC-UNRWA. In spite of the lack of trustworthiness of the diabetic guideline, most 
respondents in both settings had a positive attitude toward guidelines in general, but this 
attitude was not a predictor of guideline adherence.
conclusion: The good validity and reliability of our questionnaire can provide support 
for the accuracy of our findings. Multifaceted implementation strategies targeting the 
main barriers elicited from this study are required for addressing the lack of incentives, 
organizational resources, lack of confidence in the guideline, and time constraints.
Keywords: barriers, adherence, clinical practice guideline, diabetes mellitus, psychometric properties
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inTrODUcTiOn
Diabetes Mellitus (DM) is a serious chronic disease and an 
increasingly important public health issue. It is a major cause 
of blindness, kidney failure, heart attacks, stroke, and lower 
limb amputation (1). The World Health Organization (WHO) 
estimates that, worldwide, about 422 million people aged over 
18 years have diabetes in 2014 with a global prevalence of 8.5% 
among adult population (1). The highest prevalence rate (13.7%) 
of DM is in the WHO-Eastern Mediterranean Region (1). It was 
the eighth leading cause of death among both sexes in 2012 
(1). In Palestine, it has been projected that the prevalence of 
DM among Palestinians will be approximately 23.4% in 2030 
(2). The primary health-care services in Palestine are delivered 
by two main providers; the Ministry of Health (MoH) and the 
United Nations Relief and Works Agency for Palestine Refugees 
in the Near East (UNRWA). Both of the MoH and UNRWA are 
structurally, functionally, and financially separated and provide 
an extensive range of community health services. The UNRWA 
provides its services to Palestinian refugees only whereas the 
MoH is responsible to provide its services to refugees and non-
refugees. The refugees patients receive free of charge services 
from the UMRWA, while the patients who seek the care in 
the MoH should be insured and pay the cost sharing. On the 
other hand, the UNRWA personnel receive salaries of 1.5 times 
higher than in the MoH. Unlike the MoH, the UNRWA has its 
own regular budget, which has contributed in continuing the 
availability of medical supplies (e.g., medicines, laboratory 
consumables, and medical equipment). Moreover, the UNRWA 
has its own systematic training programs while the MoH often 
relies on donor projects who can secure the funds for training 
activities and provide most of training materials. The daily 
average number of patient seen by physicians in the UNRWA 
was 82 in 2016 (3) and estimated to be 48 in MoH. In the Gaza 
Strip, the diabetic patients receive their health care through 49 
clinics in the PHC-MoH and 22 clinics in the PHC-UNRWA. 
The Palestinian CPG for DM was adapted from international 
guidelines and targeted the areas of screening, diagnosis, and 
treatment in order to standardize the care provided to patients 
with Type 1 and Type 2 diabetes (4).
Clinical Practice Guidelines (CPGs) are “systematically devel-
oped statements to assist practitioners’ and patients’ decisions 
about appropriate health care for specific clinical circumstances” 
(5). The interest in the CPGs as an important knowledge transla-
tion tools has been increasing in the past decade (6). They are 
recognized as tools for advancement of evidence based medi-
cine, are useful tools for improving the quality of services, can 
improve patient outcomes, and contain the costs by decreasing 
unnecessary variations in care (7). In spite of the huge numbers 
of the internationally produced and implemented CPGs, the 
compliance with them is still low among health-care workers 
(8, 9). Several studies revealed that the CPGs achieved moderate 
results in changing the process of care (10, 11). In USA, only about 
55% of the patients received the care based on the CPG recom-
mendations (12). Such poor adherence to CPGs does not merely 
lead to provision of suboptimal care, but it can threaten patient 
safety, waste resources, and create poor health outcomes (13). 
Despite the great endeavors to translate guidelines into clinical 
practice, their implementation is a complicated process influ-
enced by many variables such as professional’s behavior, the 
guidelines themselves, and the method of implementing the rec-
ommendations (14). A systematic review of 76 published study 
included 120 survey conducted by Cabana and his colleagues on 
barriers to physician guideline adherence in relation to behavior 
change (14). They developed a framework, which comprises of 
seven general barriers that are classified into three main catego-
ries: knowledge related barriers (lack of familiarity and lack of 
awareness); attitude-related barriers (lack of agreement, lack of 
self-efficacy, lack of outcome expectancy, and lack of motiva-
tion/inertia of previous practice); and behavior-related barriers 
(patient factors, guideline factors, and environment factors). 
The appropriate analysis of the factors hindering the health-care 
professionals from being able to practically implement the CPGs 
is the main initial step toward enhancing the adherence to CPGs 
(15). This study aimed at exploring the adherence level and the 
most perceived barriers of the adherence to the CPG for DM 
in both the PHC-MoH and PHC-UNRWA using a validated 
questionnaire.
MaTerials anD MeThODs
study Design and sampling
A cross-sectional design was employed with a census sample of 
all Palestinian family doctors and nurses (n = 323) who worked 
with chronic patients in 71 PHCc (49 in the MoH and 22 in the 
UNRWA) in Gaza Strip. The total number of eligible doctors and 
nurses working in the PHC-MoH was 124 and 51, respectively, 
while the total number of eligible doctors and nurses working in 
the PHC-UNRWA was 115 and 56, respectively. All those work-
ing doctors and nurses with at least 1 year working experience 
were included.
Questionnaire Development
Based on the Cabana Framework (14), this questionnaire was 
designed after reviewing the previous relevant questionnaires. 
Most of the relevant items measuring the constructs of Cabana 
framework were adapted and considered. Specific items of the 
dimensions (organizational constraints, lack of resources, and 
lack of reimbursements) were tailored to match with the local 
context. A preliminary questionnaire with 54 items (11 dimen-
sions) to assess the barriers of adherence to CPG for DM and 
10 items to assess the demographic and work background were 
included. Another 10 key recommendations derived from the 
Palestinian CPG for DM were included to measure the adherence 
level. A 5-point Likert scale was used for response categories 
with the rating scale of “strongly agree,” “agree,” “neither agree 
nor disagree,” “disagree,” and “strongly disagree.”
Translation and Validation of the 
Questionnaire
The guideline of cross cultural adaptation process was recruited in 
translation of the questionnaire (16) where the detailed steps are 
described in Figure 1. In order to check face and content validity, 
FigUre 1 | The steps of questionnaire translation.
3
Radwan et al. Attitudes toward Diabetes Guideline
Frontiers in Endocrinology | www.frontiersin.org October 2017 | Volume 8 | Article 288
the final draft Arabic questionnaire was independently validated 
by 10 experts (academics, health experts, endocrinologists, and 
family doctors). Content Validity Index was calculated to rate the 
relevance of the questionnaire items (17). All items were rated 
as relevant with scores over 0.87. Slight editorial changes in the 
wording and the structure of the key recommendations items 
were made based on the consensus among the author (MR), two 
endocrinologists, and one family doctor. Finally, the question-
naire was piloted among 30 of the eligible participants. The results 
of the pilot study revealed a good overall Cronbach’s alphas of 
0.85, while the internal consistency of the domains ranged 
between 0.60 and 0.91.
Data collection
From June 2016 to August 2016, data were gathered by four data 
collectors after one full day of training about the study scope 
and objectives, questionnaire items, and the potential areas for 
misconception. The face-to-face interview-based questionnaire 
was used as a method of data collection. We obtained three 
formal approvals for data collection; from the MoH, UNRWA, 
and the Palestinian health research council in Gaza. This council 
was formed by the MoH and, after 2012, it has been officially 
delegated as an independent council with full responsibility to 
ensure keeping of all research ethical standards. Oral approvals 
were taken from all respondents before participation in this study.
Data analysis
Data analysis was carried out with SPSS version 20. The codes 
of the negative worded questions were reversed before data 
analysis. Descriptive statistics were used to describe the sample 
characteristics. Categorical variables were described using 
frequencies and percentages, whereas means and SDs were 
used to represent continuous data. P-values of 0.05 or less were 
considered significant. Psychometric properties of the study 
questionnaire were assessed by.
Construct Validity (Factor Analysis)
An exploratory factor analysis was conducted to explore the 
construct and underlying factor structure of the questionnaire. 
Extraction was performed using Principal Components Analysis 
(PCA) with Varimax rotation (18). Kaiser normalization was 
used to assess the appropriateness for factor analysis and sample 
adequacy. Outcomes of the exploratory factor analysis were 
considered accurate if the Kaiser–Meyer–Olkin (KMO) measure 
of sampling adequacy of ≥0.7, and Bartlett’s test of Sphericity with 
a P-value of <0.001 (19). The Kaiser Criterion with eigenvalues 
of ≥1 (20) was used to identify the number of extracted factors. 
Items with a factor loading of more than 0.40 were included in the 
retained factors. Item loading is an important indicator during 
factor analysis, which indicates of the correlation strength of each 
retained item to the underlying factor (domain).
TaBle 1 | Exploratory factor analysis of overall questionnaire (n = 53).
Factors item number item loading eigenvalues explained 
variance, %
cronbach 
α
F1—agreement Q32, Q33, Q34, Q35, Q36, Q37, 
Q38, Q39, Q40, Q41, Q42
0.845, −0.784, −779, 0.719, 0.859, −0.858, 0.837, 
0.835, −755, 0.853, 0.824
14.34 26.55 0.95
F2—knowledge and skills Q22, Q24, Q25, Q26, Q27, Q28, 
Q29, Q30, Q31, 43, Q45
0.719, 0.671, −0.808, 0.723, 0.614, 0.735, 0.858, 
0.593, 0.634, −0.780, −0.805
10.02 18.55 0.93
F3—lack of recourses Q23, Q57, Q58, Q59, Q60, Q61, 
Q62
0.647, 0.735, 0.752, −0.583, −0.853, −0.856, 
−0.680
3.53 6.55 0.92
F4—motivation/Inertia of 
previous practice
Q44, Q46, Q47, Q48, Q49, Q50 0.497, 0.590, 0.781, 0.758, 0.815, 0.526 2.48 4.60 0.88
F5—lack of time Q51, Q52, Q53, Q54 0.834, 0.843, 0.835, 0.860 2.03 3.77 0.91
F6—patients factors Q72, Q73, Q74, Q75 0.805, 0.775, 0.787, 0.702 1.78 3.29 0.83
F7—lack of incentives Q63, Q64, Q65, Q66 0.479, 0.800, 0.779, 0.683 1.56 2.90 0.88
F8—guideline trustworthiness Q70, Q71 0.857, 0.884 1.37 2.54 0.90
F9—organizational support Q55, Q56 0.702, 0.695 1.20 2.23 0.92
F10—guideline clarity Q67, Q68, Q69 −0.504, 0.595, 0.581 1.09 2.02 0.62
Overall 73.04 0.93
Extraction Method: principal component analysis.
Rotation Method: Varimax with Kaiser Normalization.
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Internal Consistency Reliability
Internal consistency reliability of the questionnaire was assessed 
by calculating Cronbach’s alpha coefficient of the overall question-
naire and the identified domains where score over than 0.70 were 
considered good, reflecting the internal correlation between items 
of the same area (21). Since the questionnaire encompasses many 
negatively worded items, reverse coding was conducted to make 
sure that a higher score always means a more positive response.
resUlTs
Psychometric Properties of the 
Questionnaire
Factor Analysis
In this study, the sample size was quite adequate for factor analysis 
as the KMO measure was 0.90. Such a high value can yield reliable 
factors (22). Bartlett’s test of Sphericity demonstrated that the inter-
item correlations were highly significant (χ2 = 15,166.2; df = 1,431; 
P < 0.001). The PCA analysis indicated a total of 10 factors with 
eigenvalues of ≥1, which accounted for 73.04% of the variance 
(Table 1). The new factors structure seems to be highly reasonable 
and reflects a more conceptual construct over this data set.
Internal Consistency Reliability
After conducting the construct validation, the Cronbach’s alpha 
was computed (Table 1). The overall Cronbach’s alpha was 0.93, 
which indicates a high correlation and consistency between the 
items and the questionnaire. The internal consistency of the new 
factors ranged between 0.83 and 0.95 and considered very good 
except one factor with α Cronbach 0.68.
respondent characteristics
Of the 346 eligible participants, 323 responded to the interview 
based questionnaires yielding a response rate of 93.3%. The 
respondent characteristics are summarized in Table 2.
adherence to Diabetic guideline
Table  3 shows that the overall adherence mean score across 
the key recommendations was (51.5%, SD = 7.3). Significantly 
higher total adherence was found in the PHC-UNRWA (55.5%, 
SD  =  5.7) compared to the PHC-MoH (47.3%, SD  =  6.3) 
P = 0.000. A small proportion of the respondents 11.5% (1.3% 
in PHC-MoH and 21.3% in PHC-UNRWA) claimed that they 
were always or often adherents to implementing the key recom-
mendations. The vast majority 84.2% (89.9% in PHC-MoH and 
78.7% in PHC-UNRWA) claimed that they were sometimes 
adherents to implementing the key recommendations. The least 
adherence was on the recommendation to perform screening 
for type 2 DM in all individuals at age of ≥45 years old (0.6% 
in PHC-MoH and 2.4% in PHC-UNRWA) followed by the 
prescription of angiotensin-converting-enzyme inhibitor to 
normotensive type 2 patients if urine albumin/creatinine ratio 
is positive 3  months later (1.3% in PHC-MoH and 7.3% in 
PHC-UNRWA).
The Perceived Barriers of adherence  
to the Diabetic guideline
Table 4 shows the following results.
Knowledge and Skills
The mean score of the knowledge and skills was 67.2%, SD = 16.1. 
Significantly higher total knowledge and skills was found in the 
PHC-UNRWA (75.4%, SD = 13.7) compared to the PHC-MoH 
(58.6%, SD = 14.0) P = 0.000. Compared to 44.7% in the PHC-
MoH, the vast majority of doctors and nurses (85.4%) in the PHC-
UNRWA claimed that they had the adequate knowledge and skills 
to implement the recommendations of the diabetic guideline.
Agreement
The mean score of the professionals attitude toward the guide-
lines in general was 78.8%, SD =  17.2. There were insignificant 
TaBle 2 | Respondent characteristics (n = 323).
Phc-Moh (n = 159) Phc-UnrWa (n = 164) Overall N = 323
attributes n % n % N %
Sex Male 97 61.0 93 56.7 190 58.8
Female 62 39.0 71 43.3 133 41.2
Age <35 38 23.9 58 35.4 96 29.7
35–44 70 44.0 64 39.0 134 41.5
45–60 51 32.1 42 25.6 93 28.8
M (SD) 40.70 (7.91) 39.38 (8.32) 40.03 (8.13)
Qualification Diploma 11 6.9 19 11.6 30 9.3
Bachelor 119 74.8 118 72.0 237 73.4
Postgrad 29 18.3 27 16.4 56 17.3
Specialization Medicine 114 71.7 111 67.7 225 69.7
Nursing 45 28.3 53 32.3 98 30.3
Position Practitioner 126 79.2 152 92.7 278 86.1
Manager 33 20.8 12 7.3 32 9.9
Total work experience ≤5 years 34 21.4 42 25.6 76 23.5
6–10 years 38 23.9 49 29.9 87 26.9
11–20 years 63 39.6 42 25.6 105 32.5
>20 years 24 15.1 31 18.9 55 17.0
M (SD) 12.96 (8.00) 12.27 (10.00) 12.6 1 (8.35)
Current work experience ≤5 years 57 35.8 80 48.8 137 42.4
6–10 years 58 36.5 46 28.0 104 32.2
≥11 years 44 27.7 38 23.2 82 25.4
M (SD) 8.42 (5.53) 8.33 (6.69) 8.37 (6.14)
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differences in attitude toward the CPGs among respondents 
working in the PHC-MoH (79.4%, SD =  16.5) and the PHC-
UNRWA (78.1%, SD = 17.9) P = 0.507. Most of the PHC-MoH 
participants (88%) and PHC-UNRWA participants (85.4%) agreed 
that the CPGs are good educational tools. The vast majority of 
PHC-MoH participants (90.6%) and the PHC-UNRWA partici-
pants (88.4%) agreed that implementing the diabetic guideline rec-
ommendations lead to improvement in the quality of health care.
Motivation/Inertia of Previous Practice
The mean score of the motivation/inertia of previous practice 
was 78.6%, SD = 14.5. Most of respondents in the PHC-UNRWA 
(82.1%, SD = 13.3) were more likely to be motivated than in the 
PHC-MoH (75.0%, SD = 14.9) P = 0.000. More than 93% and 
86% of respondents in the PHC-UNRWA and the PHC-MoH, 
respectively, reported that they were enthusiastic to comply 
with implementing the diabetic guideline and they were able 
to cope with the change toward working under standardized 
instructions.
Lack of Time
The mean score of the lack of time was 37.8%, SD = 16.2. There 
was significant variation in perceiving the lack of time among 
doctors and nurses working in the PHC-MoH (34.6%, SD = 14.1) 
and the PHC-UNRWA (40.8%, SD = 17.5) P = 0.001.
Organizational Constraints
The mean score of the organizational constraints was 47.0%, 
SD = 21.8. Doctors and nurses in the PHC-MoH (37.2%, SD = 13.6) 
were more likely to perceive the organizational constraints than 
in the PHC-UNRWA (56.4%, SD = 24.1) P = 0.000. Only 8.3% 
of the participants in the PHC-MoH compared to 43.9% in the 
PHC-UNRWA stated that the top management is committed 
with supporting the implementation of diabetic guideline and 
the job description facilitates its implementation.
Lack of Resources
The mean score of the lack of resources was 52.8%, SD = 22.0. 
Significantly wide variation in perceiving the lack of resources 
was shown between the PHC-MoH (34.6%, SD = 11.5) and the 
PHC-UNRWA (70.5%, SD = 13.8) P = 0.000.
Lack of Incentives
The mean score of the lack of incentives was 43.5%, SD = 19.8. 
More than half of the respondents in the PHC-UNRWA (52.8%, 
SD =  19.5) agreed more favorably with the current incentives 
than those in the PHC MoH (33.8%, SD = 14.8) P = 0.000.
Guideline Trustworthiness
The mean score of the professionals perception toward the trust-
worthiness of diabetic guideline was 39.1%, SD = 13.8. Perception 
of guideline trustworthiness yielded a statistically significant dif-
ference (P = 0.000) among participants in the PHC-MoH (34.9%, 
SD = 12.0) and in the PHC-UNRWA (43.1%, SD = 14.2).
Guideline Clarity
The mean score of the guideline clarity was 50.8%, SD =  16.8. 
Significantly higher score of the guideline clarity was revealed 
in the PHC-UNRWA (55.2%, SD  =  17.8) compared to the 
PHC-MoH (46.2%, SD = 14.4) P = 0.000. Compared to 33.6% 
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of the respondents in the PHC-UNRWA, only 18.3% in the 
PHC-MoH claimed that the layout of the diabetic guideline was 
well-coordinated and its key recommendations were specific and 
unambiguous.
Patient Factor
The mean score of the patient factor was 76.9%, SD =  13.7. 
Statistically insignificant variation (P  =  0.481) in perceiving 
the patient factor was shown between the PHC-MoH (77.5%, 
SD  =  13.3) and the PHC-UNRWA (76.4%, SD  =  14.2). The 
overwhelming majority of doctors and nurses in the PHC-
MoH (91.2%) and the PHC-UNRWA (91.4%) agreed that the 
diabetic patients wanted doctors to comply with the diabetic 
guideline and the patient’s preferences were consistent with its 
recommendations.
DiscUssiOn
We developed and tested a questionnaire assessing the barriers 
of adherence to the CPG for DM. The analysis showed very good 
psychometric properties. It had a good construct validity and 
internal consistency reliability. To the best of our knowledge, this 
is the first study to assess the factors hindering the adherence 
to the CPG for DM in the Palestinian PHC-MoH and PHC-
UNRWA by using a valid and reliable questionnaire based on 
a previously popular framework (14). The overall adherence 
level was suboptimal (51.5%). In Indonesia, the adherence to 
the recommendations of diabetic guideline was low and varied 
between 2 and 45% (23). In West Bank/Palestine, only 21.0% 
of the professionals widely implemented the diabetic guideline 
(24), whereas, in Egypt, 43.3% of the family physicians were 
appropriately adherent to diabetic neuropathy guideline (25). 
Generally, the adherence to CPGs is moderate (14) or even low 
(8). Many systematic reviews pointed out that most of the adher-
ence enhancing interventions had only modest to moderate 
effects (6, 26). Such limited effects might be due to the improper 
use of the behavioral and organizational theories as a guide for 
enhancing the adherence (27). Therefore, we employed a popular 
theoretical framework and went through the analysis of the bar-
rier factors as an initial step toward understanding the profes-
sionals’ perspectives and enhancing the adherence interventions 
(15). Overall, our study showed that there were many significant 
differences in perceiving the barriers and adherence among the 
health-care professionals in the PHC-MoH and PHC-UNRWA 
except for the attitude/agreement and patient factor. We can 
initially exclude the attitudinal barrier toward the guideline 
adherence since doctors and nurses in the PHC-MoH and the 
PHC-UNRWA had a similarly quite positive attitude toward the 
CPGs (28). Most of the PHC-MoH participants (88%) and PHC-
UNRWA participants (85.4%) agreed that the CPGs are good 
educational tools (29). The vast majority of PHC-MoH partici-
pants (90.6%) and the PHC-UNRWA participants (88.4%) agreed 
that implementing the diabetic guideline recommendations lead 
to improvement in the quality of health care (28). A possible 
explanation for this positive attitude is that the overwhelming 
vast majority of the participants in both settings agreed that the 
diabetic patients wanted doctors to comply with the diabetic 
TaBle 4 | Perceived Barriers of adherence to the diabetic guideline.
Barriers Work setting 5&4 3 2&1 N Mean sD t P-value
n (%) n (%) n (%)
1 Knowledge and skills PHC-MoH 71 (44.7) 78 (49.1) 10 (6.2) 159 58.68 14.00 −10.872 0.000
PHC-UNRWA 140 (85.4) 23 (14.0) 1 (0.6) 164 75.46 13.73
2 Agreement PHC-MoH 163 (85.6) 17 (10.6) 6 (3.8) 159 79.45 16.57 0.665 0.507
PHC-UNRWA 132 (80.5) 27 (16.5) 5 (3.0) 164 78.17 17.99
3 Motivation/inertia of previous practice PHC-MoH 137 (86.2) 19 (11.9) 3 (1.9) 159 75.01 14.93 −4.528 0.000
PHC-UNRWA 153 (93.3) 10 (6.1) 1 (0.6) 164 82.13 13.31
4 Lack of time PHC-MoH 28 (17.0) 68 (41.5) 68 (41.5) 159 40.88 17.59 −3.481 0.001
PHC-UNRWA 10 (6.3) 56 (35.2) 93 (58.5) 164 36.68 14.17
5 Organizational constraints PHC-MoH 13 (8.2) 86 (54.1) 60 (37.7) 159 37.29 13.62 −8.760 0.000
PHC-UNRWA 72 (43.9) 73 (44.5) 19 (11.6) 164 56.46 24.10
6 Lack of resources PHC-MoH 7 (4.4) 42 (26.4) 110 (69.2) 159 34.64 11.53 −25.227 0.000
PHC-UNRWA 163 (82.9) 23 (14.0) 5 (3.1) 164 70.52 13.87
7 Lack of incentives PHC-MoH 18 (11.3) 32 (20.1) 109 (68.6) 159 33.86 14.86 −9.818 0.000
PHC-UNRWA 64 (39) 70 (42.7) 30 (18.3) 164 52.89 19.57
8 Guideline trustworthiness PHC-MoH 15 (9.5) 60 (37.7) 84 (52.8) 159 34.96 12.05 −5.524 0.000
PHC-UNRWA 38 (23.1) 79 (48.2) 47 (28.7) 164 43.10 14.29
9 Guideline clarity PHC-MoH 29 (18.3) 95 (59.7) 35 (22.0) 159 46.28 14.47 −4.913 0.000
PHC-UNRWA 55 (33.6) 97 (59.1) 12 (7.3) 164 55.20 17.89
10 Patient factor PHC-MoH 145 (91.2) 13 (8.2) 1 (0.6) 159 77.54 13.33 0.705 0.481
PHC-UNRWA 150 (91.4) 12 (7.3) 2 (1.3) 164 76.46 14.24
Adherence PHC-MoH 159 47.35 6.30 −12.156 0.000
PHC-UNRWA 164 55.54 5.79
5, 4, 3, 2, and 1 indicate respondents strongly agree, agree, are neutral, disagree, and strongly disagree, respectively.
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guideline and the patient’s preferences were consistent with 
its recommendations. However, such attitude can favorably be 
invested to as a key potential factor in the implementation of 
CPGs.
The better adherence to the diabetic guideline in the PHC-
UNRWA compared to the PHC-MoH may reflect the higher 
levels of awareness and familiarity in the UNRWA settings. 
In comparison with (85.9%) of the PHC-UNRWA doctors and 
nurses, only 27.1% of the PHC-MoH doctors and nurses were 
aware about the availability of the diabetic guideline copies. 
In West Bank/Palestine, only 35.9% of professionals had a copy 
of the diabetic guideline (24), while in Estonia, 76% of doctors 
had a copy of the diabetic guideline available (30). The dominant 
minority (6.3%) of the PHC-MoH had an easy access to the guide-
line at any time compared to (82.3%) in the PHC-UNRWA. The 
relatively poor knowledge in the PHC-MoH is more likely due 
to the poor dissemination strategy. The inadequate production 
and dissemination of the guidelines might cause the unfamiliarity 
with them (31). Previous studies indicated that knowledge is a 
key factor for a greater adherence to the diabetic CPGs (32, 33); 
nonetheless, high awareness about the diabetic guideline does not 
necessarily guarantee the adherence to its recommendations (23). 
Although the appropriate knowledge and positive attitude are 
indispensable, but they do not guarantee the guideline adherence 
(14). However, the poor adherence suggests that the health-care 
professionals seem to be confronted with the external related 
barriers rather than the attitude or knowledge factors.
The most frequently perceived barriers in the PHC-MoH were 
the lack of incentives, lack of resources, and lack of the guideline 
trustworthiness, whereas the lack of time and the lack of the 
guideline trustworthiness were the most prominent barriers in 
the PHC-UNRWA. The motivational incentives were much less 
mentioned by the professionals in the PHC-MoH compared to 
the professionals in the PHC-UNRWA. The lack of incentives was 
identified as a barrier for implementing the diabetic guideline 
(34). Our study revealed that the overwhelming majority of 
PHC-MoH respondents (92.4%) stated that the current monthly 
salary, the encouragement by work colleagues (88.6%), and the 
acknowledgment by line and senior management (80.5%) did 
not motivate them to comply with the diabetic guideline. In 
the absence of conclusive evidence on the impact of financial 
incentives on the quality of diabetic management, a recently 
systematic review concluded that the pay for performance have 
variable impacts on physician behavior (35). Another study to 
assess the impact of financial incentives on providers’ adherence 
to evidence-based smoking cessation practice guidelines revealed 
that financial incentives alone did not result in recommendations 
adherence (36). It seems sensible to analyze what could motivate 
the health-care professionals prior any guideline implementation. 
Hence, the Palestinian national payment method and the incen-
tive scheme should be carefully reviewed and redesigned, taking 
into account the monetary and non-monetary incentives.
The lack of resources at the PHC-MoH played a main role in 
impeding the adherence to the diabetic guideline. Availability of 
resources such as lab equipment and medications has been identi-
fied as a main contributor to implementing the diabetic guideline 
(33). Similarly, all participants identified inadequacy of resources 
as the main barrier to the implementation of the national stroke 
8Radwan et al. Attitudes toward Diabetes Guideline
Frontiers in Endocrinology | www.frontiersin.org October 2017 | Volume 8 | Article 288
CPGs (37). The MoH essential drugs and medical disposables 
lists include about 480 item of drugs and more than 900 item 
of medical disposables. Mostly, more than 40% of these needed 
items are either completely unavailable or in critically low stocks 
(38). This chronic lack of essential drugs and disposables could 
largely impede the proper adherence to the guideline recom-
mendations and consequently pose a very serious threat to the 
patient treatment regimen. A logic explanation for the difference 
in the adherence to the recommendations of diabetic guideline 
(e.g., doing HbA1c) between the MoH and UNRWA is the lack of 
resources. Although the lack of resources is extremely challeng-
ing in the Palestinian context, the decision makers are strongly 
invited to judge the most efficient ways for rational use of the 
scarce resources (6).
The lack of the guideline trustworthiness as the third per-
ceived barrier affected the professionals both in the PHC-MoH 
and PHC-UNRWA. Lack of agreement with the guideline recom-
mendations due to less trust in them and their inapplicability was 
perceived as the most prominent barrier among Dutch general 
practitioners (39). Our analysis showed that all of the PHC-MoH 
respondents (100%) and (95.1%) of the PHC-UNRWA respond-
ents claimed that the diabetic guideline had not been developed 
based on rigorous evidences, in the same time, 83% of the PHC-
MoH respondents and 63.4% of the PHC-UNRWA respondents 
claimed that it had not been developed by professional experts. 
Someone could argue this finding and suggest interpretation as 
that the diabetic guideline has not been sold well to the health 
professionals. However, our finding is robustly supported by a 
recent study aimed at assessing the methodological quality of the 
current diabetic guideline using the AGREE II instrument, which 
revealed that the largest domain of “Rigor of Development” had 
a weak score (40). Therefore, it is crucial for guideline developers 
to consider the systematic approach in synthesizing the evidences 
and selecting the recommendations. Using the published Arabic 
version of the AGREE II instrument as a valid appraisal tool is 
strongly recommended for developing, adopting, adapting, or 
updating any future guideline.
The most common barrier cited by the PHC-UNRWA 
respondents was the lack of time. The massive majority of 
doctors and nurses (93.7%) in the PHC-UNRWA claimed that 
implementing the diabetic guideline adds extra efforts over 
their essential assigned tasks. More than 91% of them reduced 
the consultation time with diabetic patients due to the heavy 
workload and 93% were unable to adhere to the guideline rec-
ommendations due to the large numbers of outpatient visitors. 
Time constraints and pressure of work have been found to be 
main challenges to the guideline implementation (33). It could 
be suggested to analyze the workloads prior the implementation 
of guidelines or at least ensure that the available numbers of 
professionals are adequate.
strengths and limitations
The evaluation of the barriers to the CPG for DM was totally 
based on a common and widely used theoretical framework by 
Cabana et al. (14). Many steps were taken to assess the validity 
and reliability of the developed questionnaire and this provide 
support for the trustworthiness of our findings. The adherence 
was assessed based on 10 key recommendations elicited from 
the exiting diabetic guideline in order to ensure a common 
understanding among participants and achieve a maximum 
representation of the various main recommendations. A poten-
tial limitation of our study is the reliance on self-reported data, 
which may led to recall bias and social desirability bias. In spite 
of such limitation, there is evidence revealed that self-reporting 
is a valid and reliable source for assessing the physician’s perfor-
mance since its findings are quite congruent with the findings of 
the medical records (41).
cOnclUsiOn
The results of our analysis give considerable support to the Cabana 
theoretical framework, as a model for assessing the barriers 
and enablers to the CPGs. Our study shows that the adherence 
to CPG for DM in the PHC-UNRWA is a bit higher than in 
the PHC-MoH, and the perceived barriers among doctors and 
nurses in the PHC-MoH were higher than their counterparts in 
the PHC-UNRWA. The most perceived barriers among doctors 
and nurses in the PHC-MoH were lack of incentives, lack of 
resources, and lack of the guideline trustworthiness, while the 
lack of time was the most eminent barrier in the PHC-UNRWA 
followed by lack of the guideline trustworthiness. Despite the 
generally positive attitude toward guidelines among doctors 
and nurses in both PHC-MoH and PHC-UNRWA, it was not a 
predictor of guideline adherence (29). The knowledge was higher 
among the professionals in the PHC-UNRWA than in the PHC-
MoH, and it appears to be a predictor of guideline adherence. 
Multifaceted implementation strategies targeting the main barri-
ers elicited from this study are extremely required for addressing 
the incentives, organizational resources, the rigor of guideline 
development, and time constraints. Recent evidence concluded 
that a tailored implementation strategy targeting perceived bar-
riers is useful for improving the guideline adherence (42). Further 
qualitative studies to allow a better and deep understanding of 
the factors influencing the appropriate adherence of the CPGs 
are widely encouraged.
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